Eduardo Manuel Hintze da Paz Ferreira
Corporate Officer/Principal bij University of Lisbon
Oorsprong van het eerstegraads netwerk van Eduardo Manuel Hintze da Paz Ferreira
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Lisbon
11
| College/University | Other Consumer Services | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Eduardo Manuel Hintze da Paz Ferreira via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BANCO ESPÍRITO SANTO, S.A. | Regional Banks | Chairman Director/Board Member | |
| BANCO COMERCIAL PORTUGUÊS, S.A. | Major Banks | Director/Board Member Chairman Director/Board Member | |
| EDP - ENERGIAS DE PORTUGAL, S.A. | Electric Utilities | Francisco de la Fuente Sánchez | Chairman Director/Board Member Director/Board Member |
| BANK MILLENNIUM S.A. | Regional Banks | Director/Board Member | |
Union de Crédit Pour le Bâtiment SA
 Union de Crédit Pour le Bâtiment SA Finance/Rental/LeasingFinance Part of BNP Paribas SA, Union de Crédit Pour le Bâtiment SA is a mortgage services provider based in Paris, France. | Finance/Rental/Leasing | Chief Tech/Sci/R&D Officer | |
Banco Santander Totta SA
 Banco Santander Totta SA Major BanksFinance Banco Santander Totta SA is a holding company engaged in the provision of commercial banking and financial services to corporate and individual clients. It offers savings and deposit accounts, mortgages, business loans, personal loans, financing, and insurance. It also provides investment fund management, portfolio management, and financial advisory services. The company was founded in 1843 and is headquartered in Lisbon, Portugal. | Major Banks | Chief Executive Officer | |
International Society for Cellular Therapy
 International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Birmingham | College/University | Doctorate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ISCTE-Instituto Universitário de Lisboa | College/University | Undergraduate Degree | |
| Universidade Nova de Lisboa | College/University | Graduate Degree | |
| Portuguese Catholic University | College/University | Undergraduate Degree | |
| University of Coimbra | College/University | Undergraduate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
| GREENVOLT - ENERGIAS RENOVÁVEIS, S.A. | Electric Utilities | Director/Board Member | |
Schwartz Pharma AG
 Schwartz Pharma AG Pharmaceuticals: MajorHealth Technology Schwartz Pharma AG is a German company. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BANCO SANTANDER, S.A. | Major Banks | Corporate Officer/Principal | |
| TXCELL | Miscellaneous Commercial Services | Chief Operating Officer | |
| University of Aveiro | College/University | Corporate Officer/Principal | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SGPS SA
 SGPS SA Financial ConglomeratesFinance Part of Galp Energia SGPS SA, the Spanish company provides investment services. | Financial Conglomerates | Chief Executive Officer | |
Champalimaud Foundation
 Champalimaud Foundation Miscellaneous Commercial ServicesCommercial Services Champalimaud Foundation engages in the provision of biomedical research. It develops programs which provides clinical care. The company was founded by António de Sommer Champalimaud in 2004 and is headquartered in Lsbon, Portugal. | Miscellaneous Commercial Services | Chairman | |
| Associacao De Estudos Superiores De Empresa | Corporate Officer/Principal | ||
| Fundação Luso-Brasileira para o Desenvolimento do Mundo | Director/Board Member Director/Board Member | ||
| The Portuguese Bar Association of Connecticut | Corporate Officer/Principal | ||
| Nabi Pharmaceuticals | Chief Tech/Sci/R&D Officer | ||
| Portal Universia | Director/Board Member | ||
| Câmara de Comércio e Indústria Luso Espanhola | Director/Board Member | ||
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
| ULTIMOVACS ASA | Pharmaceuticals: Major | Chief Executive Officer | |
| MENDUS AB | Biotechnology | Chief Executive Officer | |
| Pfizer Saudi Ltd. | Corporate Officer/Principal | ||
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| Associação Fiscal Portuguesa | President | ||
| Católica Lisbon School of Business & Economics | College/University | Corporate Officer/Principal | |
| RFF & Associates | Founder | ||
| Instituto Latinoamericano De Derecho Tributario | President | ||
Zelluna Immunotherapy AS
 Zelluna Immunotherapy AS BiotechnologyHealth Technology Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway. | Biotechnology | Chief Executive Officer | |
| Alumni Clube Iscte | Corporate Officer/Principal | ||
Ultimovacs AB
 Ultimovacs AB Pharmaceuticals: MajorHealth Technology Part of Ultimovacs ASA, Ultimovacs AB engages in pharmaceutical development. The CEO of the Swedish company is Carlos de Sousa. Ultimovacs was acquired by Ultimovacs ASA from Immuneed AB on August 29, 2018 for $6.05 million. | Pharmaceuticals: Major | Chief Executive Officer | |
| ECTIN RESEARCH AB | Biotechnology | Director/Board Member | |
| Banco Internacional De Moçambique SA | Director/Board Member | ||
Associação Business Roundtable Portugal
 Associação Business Roundtable Portugal Miscellaneous Commercial ServicesCommercial Services Associação Business Roundtable Portugal provides business association services. The private company is based in Lisbon, Portugal. | Miscellaneous Commercial Services | Director/Board Member | |
| Conselho Superior Da Magistratura | Corporate Officer/Principal | ||
| International Society For Cell & GeneTherapy | President |
Statistieken
Internationaal
| Portugal | 23 |
| Verenigde Staten | 5 |
| Spanje | 4 |
| Zweden | 4 |
| Frankrijk | 4 |
Sectoraal
| Health Technology | 13 |
| Finance | 9 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Utilities | 3 |
Operationeel
| Director/Board Member | 48 |
| Corporate Officer/Principal | 48 |
| Chairman | 22 |
| President | 14 |
| Chief Executive Officer | 12 |
Sterkste connecties
- Beurs
- Insiders
- Eduardo Manuel Hintze da Paz Ferreira
- Bedrijfsconnecties
